Solid FY24 results, triggers to reignite growth visible
AUM was down a touch by 0.5% in FY24 (1 Oct 23 - 30 Sep 24) to £37.2bn. Net outflows totalled...
Read more
FY25 interims point to a stronger second half
For the six months to 30 September 2024 ECO Animal Health reported revenue of £33.2m, -13%YoY and...
Read moreRecent trading proves challenging
At the time of the interim results in September it was clear that Q3 trading had proven volatile....
Read moreRobust results confirm quality and growth ambition
Vp has delivered another robust H1 performance, with revenue and profits essentially in line with...
Read moreA rarity in the sector: Revenue +19%, EBITDA +34%
H1-25 (to 30 Sep 24) saw further progress of the Mercia 27 strategy which targets £3bn AUM (FUM +...
Read moreH1 25: margin improvement and FY25 outlook raised
For the six months to 30 September 2024, Supreme reported healthy revenue growth of +8%YoY (£113m)...
Read moreSteady H1, building for the future
Continuing businesses delivered H125 revenues, in line with last year’s comparator. Underlying...
Read moreDisposal of Genetics operation for £260m
Benchmark Holdings has announced the disposal of its Genetics operation to Starfish Bidco AS for an...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
